Skip to main content

Acute Coagulopathy

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Haemonetics
HaemoneticsMA - Boston
1 program
Blood product transfusion based on conventional coagulation tests.N/A1 trial
Active Trials
NCT01536496Completed114Est. Jul 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
HaemoneticsBlood product transfusion based on conventional coagulation tests.

Clinical Trials (1)

Total enrollment: 114 patients across 1 trials

NCT01536496HaemoneticsBlood product transfusion based on conventional coagulation tests.

Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma

Start: Sep 2010Est. completion: Jul 2014114 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.